Nafithromycin: Pioneering India's Indigenous Antibiotic Revolution

Abstract

Nafthromycin is a novel antibiotic derived from Streptomyces species, showing potent activity against antibiotic-resistant bacteria. India's development of Nafithromycin, the first indigenous macrolide antibiotic, is indeed a significant milestone in the global fight against antimicrobial resistance (AMR). This achievement not only underscores the nation's growing expertise in pharmaceutical research and innovation but also provides a ray of hope for combating resistant bacterial infections.